EMAIL THIS PAGE TO A FRIEND

Nature neuroscience

Determinants of different deep and superficial CA1 pyramidal cell dynamics during sharp-wave ripples.


PMID 26214372

Abstract

Sharp-wave ripples represent a prominent synchronous activity pattern in the mammalian hippocampus during sleep and immobility. GABAergic interneuronal types are silenced or fire during these events, but the mechanism of pyramidal cell (PC) participation remains elusive. We found opposite membrane polarization of deep (closer to stratum oriens) and superficial (closer to stratum radiatum) rat CA1 PCs during sharp-wave ripples. Using sharp and multi-site recordings in combination with neurochemical profiling, we observed a predominant inhibitory drive of deep calbindin (CB)-immunonegative PCs that contrasts with a prominent depolarization of superficial CB-immunopositive PCs. Biased contribution of perisomatic GABAergic inputs, together with suppression of CA2 PCs, may explain the selection of CA1 PCs during sharp-wave ripples. A deep-superficial gradient interacted with behavioral and spatial effects to determine cell participation during sleep and awake sharp-wave ripples in freely moving rats. Thus, the firing dynamics of hippocampal PCs are exquisitely controlled at subcellular and microcircuit levels in a cell type-selective manner.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA005792
Anti-PCP4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
C127
CNQX, ≥98% (HPLC), solid
C9H4N4O4
E7384
[D-Ala2, N-Me-Phe4, Gly5-ol]-Enkephalin acetate salt, ≥97% (HPLC)
C26H35N5O6
M2643
Magnesium sulfate, BioReagent, suitable for cell culture, suitable for insect cell culture
MgSO4
203726
Magnesium sulfate, ≥99.99% trace metals basis
MgSO4
M3409
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
MgSO4
83266
Magnesium sulfate solution, BioUltra, for molecular biology
MgSO4
11317
Methanesulfonic acid, PharmaGrade, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production
CH4O3S
471356
Methanesulfonic acid, ≥99.0%
CH4O3S
M4141
Methanesulfonic acid solution, 4 M (with 0.2% (w/v) tryptamine)
CH4O3S
471348
Methanesulfonic acid solution, 70 wt. % in H2O
CH4O3S
M0503
Mitomycin C from Streptomyces caespitosus, powder, contains NaCl as solubilizer
C15H18N4O5
M4287
Mitomycin C from Streptomyces caespitosus, powder, BioReagent, suitable for cell culture
C15H18N4O5
M0440
Mitomycin C from Streptomyces caespitosus, ≥970 μg/mg (USP XXIV)
C15H18N4O5
M7949
Mitomycin C from Streptomyces caespitosus, ≥98% (HPLC), potency: ≥970 μg per mg (USP XXIV), γ-irradiated, suitable for cell culture
C15H18N4O5
197378
Picric acid, moistened with water, ≥98%
C6H3N3O7
36011
Picric acid solution, 0.9-1.1% (alkalimetric)
C6H3N3O7
P6744
Picric acid solution, 1.3% in H2O (saturated)
C6H3N3O7
P1190
Potassium acetate, for molecular biology, ≥99.0%
C2H3KO2
P5708
Potassium acetate, BioXtra, ≥99.0%
C2H3KO2
P1222
Potassium acetate, meets USP testing specifications
C2H3KO2
255785
Potassium acetate, 99.98% trace metals basis, ~100 ppm Rb, <50 ppm Cs
C2H3KO2
60035
Potassium acetate, BioUltra, for molecular biology, ≥99.0% (NT)
C2H3KO2
W292001
Potassium acetate, 98%
C2H3KO2
95843
Potassium acetate solution, BioUltra, for molecular biology, 5 M in H2O
C2H3KO2
G4500
Potassium D-gluconate, ≥99%
C6H11KO7
P1847
Potassium gluconate, meets USP testing specifications, anhydrous
C6H11KO7